![]()
Gene-Chemical Interaction Annotations Click to see Annotation Detail View
Term | Qualifier | Evidence | With | Reference | Notes | Source | Original Reference(s) | (R,R,R)-alpha-tocopherol | increases expression | EXP | | 6480464 | alpha-Tocopherol results in increased expression of MGAT3 mRNA | CTD | PMID:16908007 | 1,1-dichloroethene | decreases expression | ISO | RGD:736510 | 6480464 | vinylidene chloride results in decreased expression of MGAT3 mRNA | CTD | PMID:26682919 | 1,2-dimethylhydrazine | decreases expression | ISO | RGD:736510 | 6480464 | 1, 2-Dimethylhydrazine results in decreased expression of MGAT3 mRNA | CTD | PMID:22206623 | 17alpha-ethynylestradiol | increases expression | EXP | | 6480464 | Ethinyl Estradiol results in increased expression of MGAT3 mRNA | CTD | PMID:29097150 | 17beta-estradiol | increases expression | ISO | RGD:1343088 | 6480464 | Estradiol results in increased expression of MGAT3 mRNA | CTD | PMID:25321415, PMID:31614463 | 17beta-estradiol | multiple interactions | ISO | RGD:1343088 | 6480464 | [Estradiol binds to ESR2 protein] which results in increased expression of MGAT3 mRNA | CTD | PMID:20404318 | 2,3,7,8-tetrachlorodibenzodioxine | affects expression | ISO | RGD:736510 | 6480464 | Tetrachlorodibenzodioxin affects the expression of MGAT3 mRNA | CTD | PMID:24680724 | 2,3,7,8-tetrachlorodibenzodioxine | decreases expression | EXP | | 6480464 | Tetrachlorodibenzodioxin results in decreased expression of MGAT3 mRNA | CTD | PMID:33387578 | 3,3',4,4',5-pentachlorobiphenyl | decreases expression | EXP | | 6480464 | 3 more ... | CTD | PMID:23196670 | 3,3',5,5'-tetrabromobisphenol A | decreases expression | ISO | RGD:736510 | 6480464 | tetrabromobisphenol A results in decreased expression of MGAT3 mRNA | CTD | PMID:25172293 | 4,4'-diaminodiphenylmethane | decreases expression | ISO | RGD:736510 | 6480464 | 4, 4'-diaminodiphenylmethane results in decreased expression of MGAT3 mRNA | CTD | PMID:18648102 | 4,4'-sulfonyldiphenol | affects methylation | ISO | RGD:736510 | 6480464 | bis(4-hydroxyphenyl)sulfone affects the methylation of MGAT3 gene | CTD | PMID:31683443 | 5-aza-2'-deoxycytidine | affects expression | ISO | RGD:1343088 | 6480464 | Decitabine affects the expression of MGAT3 mRNA | CTD | PMID:23300844 | acrylamide | decreases expression | EXP | | 6480464 | Acrylamide results in decreased expression of MGAT3 mRNA | CTD | PMID:28959563 | aflatoxin B1 | increases methylation | ISO | RGD:1343088 | 6480464 | Aflatoxin B1 results in increased methylation of MGAT3 3' UTR, Aflatoxin B1 results in increased methylation of MGAT3 gene | CTD | PMID:27153756, PMID:30157460 | aflatoxin B1 | decreases methylation | ISO | RGD:1343088 | 6480464 | Aflatoxin B1 results in decreased methylation of MGAT3 intron | CTD | PMID:30157460 | ammonium chloride | affects expression | EXP | | 6480464 | Ammonium Chloride affects the expression of MGAT3 mRNA | CTD | PMID:16483693 | benzo[a]pyrene | affects methylation | ISO | RGD:1343088 | 6480464 | Benzo(a)pyrene affects the methylation of MGAT3 3' UTR more ... | CTD | PMID:27901495, PMID:30157460 | bis(2-chloroethyl) sulfide | increases expression | ISO | RGD:736510 | 6480464 | Mustard Gas results in increased expression of MGAT3 mRNA | CTD | PMID:15674844 | bisdemethoxycurcumin | multiple interactions | ISO | RGD:1343088 | 6480464 | [bisdemethoxycurcumin analog co-treated with APP protein] results in increased expression of MGAT3 mRNA, [bisdemethoxycurcumin co-treated with APP protein] results in increased expression of MGAT3 mRNA | CTD | PMID:22029407 | bisdemethoxycurcumin | increases expression | ISO | RGD:1343088 | 6480464 | bisdemethoxycurcumin results in increased expression of MGAT3 mRNA | CTD | PMID:19090986 | bisphenol A | decreases expression | EXP | | 6480464 | bisphenol A results in decreased expression of MGAT3 mRNA | CTD | PMID:25181051 | bisphenol A | increases expression | ISO | RGD:736510 | 6480464 | bisphenol A results in increased expression of MGAT3 mRNA | CTD | PMID:32156529 | bisphenol A | increases expression | EXP | | 6480464 | bisphenol A results in increased expression of MGAT3 mRNA | CTD | PMID:29097150, PMID:34947998 | cadmium atom | increases expression | ISO | RGD:1343088 | 6480464 | Cadmium results in increased expression of MGAT3 mRNA | CTD | PMID:24376830 | cadmium dichloride | increases expression | ISO | RGD:736510 | 6480464 | Cadmium Chloride results in increased expression of MGAT3 mRNA | CTD | PMID:24982889 | carbon nanotube | decreases expression | ISO | RGD:736510 | 6480464 | Nanotubes more ... | CTD | PMID:25554681 | carmustine | decreases expression | ISO | RGD:1343088 | 6480464 | Carmustine results in decreased expression of MGAT3 mRNA | CTD | PMID:15980968 | chlordecone | decreases expression | ISO | RGD:736510 | 6480464 | Chlordecone results in decreased expression of MGAT3 mRNA | CTD | PMID:33711761 | chromium(6+) | affects expression | ISO | RGD:736510 | 6480464 | chromium hexavalent ion affects the expression of MGAT3 mRNA | CTD | PMID:28472532 | cisplatin | multiple interactions | ISO | RGD:1343088 | 6480464 | [Cisplatin co-treated with panobinostat] affects the expression of MGAT3 mRNA | CTD | PMID:21791302 | cisplatin | increases expression | ISO | RGD:1343088 | 6480464 | Cisplatin results in increased expression of MGAT3 mRNA | CTD | PMID:27594783 | cisplatin | affects expression | ISO | RGD:1343088 | 6480464 | Cisplatin affects the expression of MGAT3 mRNA | CTD | PMID:23300844 | crocidolite asbestos | decreases expression | ISO | RGD:736510 | 6480464 | Asbestos, Crocidolite results in decreased expression of MGAT3 mRNA | CTD | PMID:29279043 | doxorubicin | decreases expression | ISO | RGD:1343088 | 6480464 | Doxorubicin results in decreased expression of MGAT3 mRNA | CTD | PMID:29803840 | endosulfan | increases expression | EXP | | 6480464 | Endosulfan results in increased expression of MGAT3 mRNA | CTD | PMID:29391264 | fenvalerate | increases expression | EXP | | 6480464 | fenvalerate results in increased expression of MGAT3 mRNA | CTD | PMID:30307764 | gentamycin | decreases expression | EXP | | 6480464 | Gentamicins results in decreased expression of MGAT3 mRNA | CTD | PMID:33387578 | lead(0) | affects expression | ISO | RGD:1343088 | 6480464 | Lead affects the expression of MGAT3 mRNA | CTD | PMID:28903495 | lead(2+) | affects expression | ISO | RGD:1343088 | 6480464 | Lead affects the expression of MGAT3 mRNA | CTD | PMID:28903495 | lipopolysaccharide | multiple interactions | ISO | RGD:1343088 | 6480464 | [S-(1 more ... | CTD | PMID:35811015 | N-nitrosodiethylamine | affects response to substance | ISO | RGD:736510 | 6480464 | MGAT3 protein affects the susceptibility to Diethylnitrosamine | CTD | PMID:12417419, PMID:14633700 | N-nitrosodiethylamine | multiple interactions | ISO | RGD:736510 | 6480464 | MGAT3 protein affects the susceptibility to [Diethylnitrosamine co-treated with Phenobarbital] | CTD | PMID:14633700 | panobinostat | multiple interactions | ISO | RGD:1343088 | 6480464 | [Cisplatin co-treated with panobinostat] affects the expression of MGAT3 mRNA | CTD | PMID:21791302 | paracetamol | decreases expression | ISO | RGD:1343088 | 6480464 | Acetaminophen results in decreased expression of MGAT3 mRNA | CTD | PMID:26690555 | paracetamol | decreases expression | EXP | | 6480464 | Acetaminophen results in decreased expression of MGAT3 mRNA | CTD | PMID:33387578 | pentanal | increases expression | ISO | RGD:1343088 | 6480464 | pentanal results in increased expression of MGAT3 mRNA | CTD | PMID:26079696 | phenobarbital | multiple interactions | ISO | RGD:736510 | 6480464 | MGAT3 protein affects the susceptibility to [Diethylnitrosamine co-treated with Phenobarbital] | CTD | PMID:14633700 | progesterone | decreases expression | ISO | RGD:736510 | 6480464 | Progesterone results in decreased expression of MGAT3 mRNA | CTD | PMID:19693291 | S-(1,2-dichlorovinyl)-L-cysteine | multiple interactions | ISO | RGD:1343088 | 6480464 | [S-(1 more ... | CTD | PMID:35811015 | S-(1,2-dichlorovinyl)-L-cysteine | decreases expression | ISO | RGD:1343088 | 6480464 | S-(1, 2-dichlorovinyl)cysteine results in decreased expression of MGAT3 mRNA | CTD | PMID:35811015 | silicon dioxide | decreases expression | ISO | RGD:1343088 | 6480464 | Silicon Dioxide analog results in decreased expression of MGAT3 mRNA | CTD | PMID:25895662 | silicon dioxide | increases expression | ISO | RGD:1343088 | 6480464 | Silicon Dioxide analog results in increased expression of MGAT3 mRNA | CTD | PMID:23806026 | sunitinib | increases expression | ISO | RGD:1343088 | 6480464 | Sunitinib results in increased expression of MGAT3 mRNA | CTD | PMID:31533062 | testosterone | increases expression | ISO | RGD:736510 | 6480464 | Testosterone results in increased expression of MGAT3 mRNA | CTD | PMID:19693291 | titanium dioxide | affects expression | ISO | RGD:736510 | 6480464 | titanium dioxide affects the expression of MGAT3 mRNA | CTD | PMID:23557971 | triptonide | decreases expression | ISO | RGD:736510 | 6480464 | triptonide results in decreased expression of MGAT3 mRNA | CTD | PMID:33045310 | valproic acid | increases methylation | ISO | RGD:1343088 | 6480464 | Valproic Acid results in increased methylation of MGAT3 gene | CTD | PMID:29154799 | valproic acid | decreases expression | ISO | RGD:1343088 | 6480464 | Valproic Acid results in decreased expression of MGAT3 mRNA | CTD | PMID:28001369 | vancomycin | increases expression | ISO | RGD:736510 | 6480464 | Vancomycin results in increased expression of MGAT3 mRNA | CTD | PMID:18930951 | zinc atom | increases expression | ISO | RGD:1343088 | 6480464 | Zinc deficiency results in increased expression of MGAT3 mRNA | CTD | PMID:22171008 | zinc(0) | increases expression | ISO | RGD:1343088 | 6480464 | Zinc deficiency results in increased expression of MGAT3 mRNA | CTD | PMID:22171008 | zoledronic acid | increases expression | ISO | RGD:1343088 | 6480464 | zoledronic acid results in increased expression of MGAT3 mRNA | CTD | PMID:24714768 | |